Literature DB >> 34424534

Longitudinal Data Discontinuity in Electronic Health Records and Consequences for Medication Effectiveness Studies.

Kueiyu Joshua Lin1, Yinzhu Jin1, Joshua Gagne1, Robert J Glynn1, Shawn N Murphy2, Angela Tong1, Sebastian Schneeweiss1.   

Abstract

Electronic health record (EHR) discontinuity (i.e., receiving care outside of the study EHR system), can lead to information bias in EHR-based real-world evidence (RWE) studies. An algorithm has been previously developed to identify patients with high EHR-continuity. We sought to assess whether applying this algorithm to patient selection for inclusion can reduce bias caused by data-discontinuity in four RWE examples. Among Medicare beneficiaries aged >=65 years from 2007 to 2014, we established 4 cohorts assessing drug effects on short-term or long-term outcomes, respectively. We linked claims data with two US EHR systems and calculated %bias of the multivariable-adjusted effect estimates based on only EHR vs. linked EHR-claims data because the linked data capture medical information recorded outside of the study EHR. Our study cohort included 77,288 patients in system 1 and 60,309 in system 2. We found the subcohort in the lowest quartile of EHR-continuity captured 72-81% of the short-term and only 21-31% of the long-term outcome events, leading to %bias of 6-99% for the short-term and 62-112% for the long-term outcome examples. This trend appeared to be more pronounced in the example using a nonuser comparison rather than an active comparison. We did not find significant treatment effect heterogeneity by EHR-continuity for most subgroups across empirical examples. In EHR-based RWE studies, investigators may consider excluding patients with low algorithm-predicted EHR-continuity as the EHR data capture relatively few of their actual outcomes, and treatment effect estimates in these patients may be unreliable.
© 2021 The Authors. Clinical Pharmacology & Therapeutics © 2021 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Year:  2021        PMID: 34424534      PMCID: PMC8678205          DOI: 10.1002/cpt.2400

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  21 in total

Review 1.  A review of uses of health care utilization databases for epidemiologic research on therapeutics.

Authors:  Sebastian Schneeweiss; Jerry Avorn
Journal:  J Clin Epidemiol       Date:  2005-04       Impact factor: 6.437

2.  The lasso method for variable selection in the Cox model.

Authors:  R Tibshirani
Journal:  Stat Med       Date:  1997-02-28       Impact factor: 2.373

3.  Building Data Infrastructure to Evaluate and Improve Quality: PCORnet.

Authors:  Douglas A Corley; Heather Spencer Feigelson; Tracy A Lieu; Elizabeth A McGlynn
Journal:  J Oncol Pract       Date:  2015-05       Impact factor: 3.840

4.  Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study.

Authors:  Tony Antoniou; Tara Gomes; David N Juurlink; Mona R Loutfy; Richard H Glazier; Muhammad M Mamdani
Journal:  Arch Intern Med       Date:  2010-06-28

5.  Identifying Patients With High Data Completeness to Improve Validity of Comparative Effectiveness Research in Electronic Health Records Data.

Authors:  Kueiyu Joshua Lin; Daniel E Singer; Robert J Glynn; Shawn N Murphy; Joyce Lii; Sebastian Schneeweiss
Journal:  Clin Pharmacol Ther       Date:  2017-10-10       Impact factor: 6.875

6.  Building electronic data infrastructure for comparative effectiveness research: accomplishments, lessons learned and future steps.

Authors:  Gurvaneet S Randhawa
Journal:  J Comp Eff Res       Date:  2014-11       Impact factor: 1.744

7.  Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care.

Authors:  Rishi J Desai; Elisabetta Patorno; Muthiah Vaduganathan; Mufaddal Mahesri; Kristyn Chin; Raisa Levin; Scott D Solomon; Sebastian Schneeweiss
Journal:  Heart       Date:  2021-06-04       Impact factor: 5.994

8.  External Validation of an Algorithm to Identify Patients with High Data-Completeness in Electronic Health Records for Comparative Effectiveness Research.

Authors:  Kueiyu Joshua Lin; Gary E Rosenthal; Shawn N Murphy; Kenneth D Mandl; Yinzhu Jin; Robert J Glynn; Sebastian Schneeweiss
Journal:  Clin Epidemiol       Date:  2020-02-04       Impact factor: 4.790

Review 9.  Prediction Score for Anticoagulation Control Quality Among Older Adults.

Authors:  Kueiyu Joshua Lin; Daniel E Singer; Robert J Glynn; Suzanne Blackley; Li Zhou; Jun Liu; Gina Dube; Lynn B Oertel; Sebastian Schneeweiss
Journal:  J Am Heart Assoc       Date:  2017-10-05       Impact factor: 5.501

10.  Pharmacotherapy for Hospitalized Patients with COVID-19: Treatment Patterns by Disease Severity.

Authors:  Kueiyu Joshua Lin; Sebastian Schneeweiss; Helen Tesfaye; Elvira D'Andrea; Jun Liu; Joyce Lii; Shawn N Murphy; Joshua J Gagne
Journal:  Drugs       Date:  2020-12       Impact factor: 11.431

View more
  1 in total

1.  Effectiveness and Safety of Reduced and Standard Daily Doses of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Cohort Study Using National Database Representing the Japanese Population.

Authors:  Kiyoshi Kubota; Nobuhiro Ooba
Journal:  Clin Epidemiol       Date:  2022-04-29       Impact factor: 5.814

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.